Radiographic PFS in Metastatic CRPC More Than Doubles With Novel Combination

[ad_1]

(MedPage Today) — SAN FRANCISCO — Radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) more than doubled with the addition of an investigational targeted therapy to standard treatment, a randomized…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/114212

Author :

Publish date : 2025-02-13 21:45:26

Copyright for syndicated content belongs to the linked Source.